CJC-1295 (No DAC) + Ipamorelin
Research-grade CJC-1295 (No DAC) + Ipamorelin, lyophilized powder, >99% HPLC purity. Third-party tested with a certificate of analysis per lot.
| Purity | >99% (HPLC) |
|---|
| Form | Lyophilized powder |
|---|
| Sizes | 5 mg / 5 mg |
|---|
Certificate of Analysis for CJC-1295 (No DAC) + Ipamorelin
Research reference
CJC-1295 without DAC, also referred to as modified GRF(1-29), is a GHRH(1-29) analogue carrying four amino-acid substitutions — D-Ala², Gln⁸, Ala¹⁵, Leu²⁷ — that confer resistance to dipeptidyl peptidase-4 and other plasma proteases. It lacks the albumin-binding drug-affinity-complex linker present in the DAC form and therefore has a substantially shorter plasma half-life, with a pharmacokinetic profile closer to native GHRH. Ipamorelin is a pentapeptide, Aib-His-D-2-Nal-D-Phe-Lys-NH₂, derived from the GHRP-1 structure, acting as an agonist at the growth hormone secretagogue receptor (GHS-R1a). Research use only. Not for human consumption.
Literature
All products are sold strictly for laboratory and research use only. Not for human or animal consumption, ingestion, injection, or diagnostic use. Not intended to diagnose, treat, cure, or prevent any disease.
